The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJRS.L Regulatory News (JRS)

  • There is currently no data for JRS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

23 Nov 2022 16:42

RNS Number : 4051H
JPMorgan Russian Securities PLC
23 November 2022
 

23 November 2022

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended ("UK MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of UK MAR. This announcement has been authorised for release by the Company's Board of Directors.

 

JPMorgan Russian Securities plc

 

Result of General Meeting

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

 

The Board of JPMorgan Russian Securities plc (the "Company") is pleased to announce that, at the general meeting of the Company held earlier today, the ordinary resolution approving and adopting the new investment objective and policy as detailed in the circular to shareholders dated 27 October 2022 (the "Circular") was duly passed by shareholders.

 

Details of the number of votes cast for, against and withheld in respect of the resolution, which was voted on by way of a poll, are set out below and will also be published on the Company's website www.jpmrussian.co.uk

 

Ordinary Resolution

Votes For (including Discretionary)

% of Votes

Votes Against

% of Votes

Votes Total

% of Issued Share Capital

Votes Withheld

To approve and adopt the new investment objective and policy as detailed in the circular published by the Company on 27 October 2022

6,317,522

61.32

3,984,512

 

38.68

 

10,302,034

25.48

2,494

 

Where 20 per cent. or more of votes have been cast against any Board recommendation for a resolution, the Company is required by provision 4 of the AIC Code of Corporate Governance to explain what action it will take to consult shareholders to understand the reasons behind the result. Following publication of the Circular, the Board has received a number of questions from shareholders regarding the proposals and understands that some shareholders are concerned whether the implementation of the new investment objective and policy would be followed by an issue of shares or capital raising that would dilute their shareholding in the Company. Some shareholders are also concerned that the Company may undertake a 'fire sale' of its Russian holdings if the Russian market reopened to the Company.

 

As noted in the RNS announcement of 7 November 2022, there are currently no plans to issue shares or raise capital, even in the event that the current prohibitions on the trading of and receipt of dividends from Russian securities are lifted. The Board is mindful of shareholders' pre-emption rights and its duty to promote the success of the Company for the benefit of the members as a whole. The Company will continue to engage with shareholders to understand their concerns. An updated list of shareholders' questions and answers (Q&A) will be uploaded onto the Company's website shortly. In addition, updates will be provided in the Company's annual report and financial statements that are expected to be released before the end of January 2023.

 

Eric Sanderson, Chairman, commented:

 

"As a Board we condemn the actions of the Russian State in Ukraine and our thoughts are with the Ukrainian people. It is a tragedy for them. We will take the approval of today's resolution to amend the Company's investment objective and policy as a step forward in attempting to avoid the crystallisation of current shareholders' losses in the Company of circa 95 per cent. The widening of the Company's investment objective is not a proposal that we would have made in normal trading conditions. However, with the situation for the Company since Russia's invasion of Ukraine on 28 February 2022 remaining unchangedand no one knowing where these tragic events will lead or what the future holds, today's approval will at least provide an opportunity for the Company to resume investment and income generation. As previously stated, the Board is conscious of existing shareholders' pre-emption rights and concerns about possible dilution of their holdings following the widening of the investment objective and it is in that context that we will implement today's mandate."

 

As set out in the Circular, following a resolution of the Board in accordance with the Company's Articles of Association, the Company intends to change its name to JPMorgan Emerging Europe, Middle East & Africa Securities plc and to update the ticker of the Company to JEMA as soon as is practicable.

 

In accordance with Listing Rule 9.6.2., a copy of the resolution has been submitted to the National Storage

Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism) and will shortly be available for inspection. The full text of the new investment objective and policy can be found in the Circular, which is also available for inspection on the National Storage Mechanism and on the Company's website (www.jpmrussian.co.uk).

 

Enquiries:

JPMorgan Funds Limited

+44 (0) 20 7742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMQXLFLLFLZFBB
Date   Source Headline
24th Nov 202211:15 amRNSNet Asset Value(s)
24th Nov 202211:07 amRNSChange of Name
23rd Nov 20224:42 pmRNSResult of General Meeting
23rd Nov 202210:48 amRNSNet Asset Value(s)
22nd Nov 202211:19 amRNSNet Asset Value(s)
21st Nov 202211:37 amRNSNet Asset Value(s)
18th Nov 202210:58 amRNSNet Asset Value(s)
17th Nov 202211:08 amRNSNet Asset Value(s)
16th Nov 202210:56 amRNSNet Asset Value(s)
15th Nov 202210:55 amRNSNet Asset Value(s)
14th Nov 202211:46 amRNSTen Largest Investments
14th Nov 202210:46 amRNSNet Asset Value(s)
11th Nov 202211:49 amRNSNet Asset Value(s)
10th Nov 202210:30 amRNSNet Asset Value(s)
9th Nov 202211:08 amRNSNet Asset Value(s)
8th Nov 202210:53 amRNSNet Asset Value(s)
7th Nov 202211:11 amRNSNet Asset Value(s)
7th Nov 20229:21 amRNSUpdate on Proposals for New Investment Objective
4th Nov 202211:20 amRNSNet Asset Value(s)
3rd Nov 202210:53 amRNSNet Asset Value(s)
2nd Nov 202210:48 amRNSNet Asset Value(s)
1st Nov 20223:17 pmRNSClosed Period Notification
1st Nov 202211:15 amRNSNet Asset Value(s)
31st Oct 202210:45 amRNSNet Asset Value(s)
28th Oct 202211:30 amRNSNet Asset Value(s)
27th Oct 202211:02 amRNSNet Asset Value(s)
27th Oct 20227:00 amRNSProposed New Investment Objective
26th Oct 202211:13 amRNSNet Asset Value(s)
25th Oct 202211:03 amRNSNet Asset Value(s)
24th Oct 202210:45 amRNSNet Asset Value(s)
21st Oct 202210:57 amRNSNet Asset Value(s)
20th Oct 202211:41 amRNSNet Asset Value(s)
19th Oct 202210:57 amRNSNet Asset Value(s)
18th Oct 202211:25 amRNSNet Asset Value(s)
17th Oct 202211:42 amRNSTen Largest Investments
17th Oct 202211:41 amRNSNet Asset Value(s)
17th Oct 202211:41 amRNSNet Asset Value(s)
17th Oct 20228:43 amRNSNet Asset Value(s)
14th Oct 202210:48 amRNSNet Asset Value(s)
13th Oct 202211:19 amRNSNet Asset Value(s)
12th Oct 202210:59 amRNSNet Asset Value(s)
11th Oct 202210:56 amRNSNet Asset Value(s)
10th Oct 202211:14 amRNSNet Asset Value(s)
7th Oct 202211:16 amRNSNet Asset Value(s)
6th Oct 202211:15 amRNSNet Asset Value(s)
5th Oct 202210:58 amRNSNet Asset Value(s)
4th Oct 202211:35 amRNSNet Asset Value(s)
3rd Oct 202211:56 amRNSNet Asset Value(s)
30th Sep 202212:20 pmRNSNet Asset Value(s)
29th Sep 202211:09 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.